title: Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-related inhibitors.
abstract: The purpose of this study was to investigate the structure-activity relationships of ghilanten, an anticoagulant-antimetastatic protein of the South American leech Haementeria ghilianii. Five sequence-related variants of ghilanten, termed P1-P5, were purified and were shown to potently block the active-site hydrolysis of methoxycarbonyl-D-cyclohexylglycyl-glycyl-arginine-p-nitroanilide acetate by the human blood coagulation enzyme factor Xa; inhibition was rapid and stoichiometric. The amino acid sequence of P5 revealed a consensus sequence for heparin-binding at the carboxy-terminus. A synthetic peptide homologous to this region (93P-N-G-L-K-R-D-K-L-G-C-E-Y-C-E-C-R-P-K-R-K-L-I-P-R-L-S119) bound 125I-labelled heparin maximally at physiological pH and salt concentration. When administered intravenously to mice, the peptide suppressed lung metastases although less potentially than whole ghilanten. These findings suggest that the carboxy-terminal heparin-binding region may play a role in the antimetastatic action of the inhibitor.
authors.affiliation: Marion Merrell Dow Research Institute, Marion Merrell Dow Pharmaceuticals, Inc., Cincinnati, OH 45215-6300.
authors.forename: R G
authors.initials: RG
authors.lastname: Brankamp
authors.forename: G G
authors.initials: GG
authors.lastname: Manley
authors.forename: D T
authors.initials: DT
authors.lastname: Blankenship
authors.forename: T L
authors.initials: TL
authors.lastname: Bowlin
authors.forename: A D
authors.initials: AD
authors.lastname: Cardin
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001665:Binding Sites; D001798:Blood Proteins / Q000235:genetics; D016384:Consensus Sequence; D004357:Drug Synergism; D015951:Factor Xa / Q000378:metabolism; D065427:Factor Xa Inhibitors; D006493:Heparin / Q000378:metabolism; D006801:Humans; D007447:Invertebrate Hormones / Q000235:genetics / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use; D007865:Leeches / Q000737:chemistry; D008175:Lung Neoplasms / Q000517:prevention & control / Q000556:secondary; D008546:Melanoma, Experimental / Q000188:drug therapy* / Q000556:secondary; D051379:Mice; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D009368:Neoplasm Transplantation; D010446:Peptide Fragments / Q000494:pharmacology / Q000627:therapeutic use; D012689:Sequence Homology, Nucleic Acid
chemical_list: D000970:Antineoplastic Agents; D001798:Blood Proteins; D065427:Factor Xa Inhibitors; D007447:Invertebrate Hormones; D010446:Peptide Fragments; C063005:ghilanten; D006493:Heparin; D015951:Factor Xa